TABLE 4

Pharmacokinetic parameters of m1A and rhodamine 123 in control and PYR-treated mice

The equations to calculate the kinetic parameters are described in Materials and Methods. Each value represents the mean ± S.E. (n = 4); Student’s two-tailed unpaired t test; value in control mice vs. PYR-treated mice.

Parameterm1ARhodamine 123
ControlPYRUnitControlPYRUnit
Cp,120 min1.64 ± 0.102.31 ± 0.13**μM5.61 ± 0.465.01 ± 0.39nM
AUCp,0–120 min140 ± 9182 ± 11*μmol per min/l564 ± 27512 ± 12nmol per min/l
Xurine170 ± 10126 ± 5**nmol477 ± 3221.2 ± 3.4***pmol
Ckidney7.22 ± 1.8234.0 ± 5.4**μM0.800 ± 0.0741.86 ± 0.21μM
Kp,kidney4.4 ± 1.114.7 ± 2.0**ml/g of kidney143 ± 6381 ± 70ml/g of kidney
CLtot,p2.32 ± 0.121.78 ± 0.13*ml/min3.93 ± 0.184.07 ± 0.05ml/min
CLtot,p80.4 ± 4.961.9 ± 3.6*ml/min per kilogram136 ± 8142 ± 2ml/min per kilogram
CLr,p1.23 ± 0.110.698 ± 0.035**ml/min0.851 ± 0.0730.0416 ± 0.0073ml/min
CLr,p42.6 ± 4.124.3 ± 0.6**ml/min per kilogram29.6 ± 3.11.44 ± 0.21ml/min per kilogram
GFR (Jonker et al., 2003)0.462 ± 0.0450.462 ± 0.065ml/min
  • Ckidney, kidney concentration; Cp,120 min, plasma concentration of compound at 120 minutes after administration; GFR, glomerular filtration rate; Xurine, amount of compound excreted in urine.

  • * P < 0.05; **P < 0.01; ***P < 0.001.